Welcome to LookChem.com Sign In|Join Free

CAS

  • or

618056-34-1

618056-34-1

Post Buying Request

618056-34-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

618056-34-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 618056-34-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,1,8,0,5 and 6 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 618056-34:
(8*6)+(7*1)+(6*8)+(5*0)+(4*5)+(3*6)+(2*3)+(1*4)=151
151 % 10 = 1
So 618056-34-1 is a valid CAS Registry Number.

618056-34-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(4,5-dimethoxy-2-{[4-methoxy-3-(phenylmethoxy)phenyl] carbonyl}phenyl)pentan-2-one

1.2 Other means of identification

Product number -
Other names 3-(4,5-dimethoxy-2-{[4-methoxy-3-(phenylmethoxy)phenyl]carbonyl}phenyl)pentan-2-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:618056-34-1 SDS

618056-34-1Relevant articles and documents

Treatment of LTB4-mediated inflammatory disorders with optically-pure (R)-2,3-benzodiazepines

-

, (2008/06/13)

Compounds according to formula I: 1wherein R1, R2, R3, R4, R5 and n are as defined herein, are administered for the treatment of inflammatory disorders mediated by LTB4,

Pharmaceutical composition of 1-(3-hydroxy-4-methoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5H-2,3-benzodiazepine and uses thereof

-

, (2008/06/13)

Pharmaceutical compositions comprise 1-(3-hydroxy-4-methoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5H-2,3-benzodiazepine, or a pharmaceutically acceptable salt thereof. The compositions are used for treating, preventing or delaying the onset of disorders mediated by LTB4 or TXA2.

Method of increasing neutrophil production using 2,3-benzodiazepines

-

, (2008/06/13)

Compounds according to formula I: wherein R1, R2, R3, R4, R5 and n are as defined herein, are administered to increase neutrophil levels in mammals.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 618056-34-1